Global rare disease specialist Raremark appoints healthtech trailblazer Dale Jessop as new CTO

Raremark®, the global healthtech company specializing in rare disease, has today announced the appointment of Dale Jessop as Chief Technical Officer.

Jessop brings a wealth of expertise and two decades worth of experience to the business, having worked for companies of all sizes, from start-ups to Fortune 100 companies. He moved into the pharma industry in 2012, joining eCOA pioneer Exco InTouch, whereas CTO, he helped the company grow from 35 to around 180 people. In the last few years, he has been part of a healthtech IPO on the London Stock Exchange and has built an eConsent platform for clinical research, which was acquired in September 2020.

As CTO of Raremark, Jessop will be responsible for developing and directing the company’s data-driven strategy for technology, as well as expanding and refining its software offerings for both patients and industry.

Commenting on the new role, Jessop said: “This is a hugely meaningful move for me. With a parent and sibling both living with a rare condition, the chance to be directly involved in this part of the healthcare sector is a real honor.”

Jessop added: “The way patients and caregivers are using technology to learn and communicate about health is changing at lightning speed and I’m very excited to join a company at the forefront of this change. The team here is incredibly talented, with a lot of innovative plans and ideas to use our technology and services as an enabler of change. I’m looking forward to adding my own experiences into the mix and bringing these ideas to life.”

Raremark has experienced accelerated levels of growth over the last 12 months, driven in part by its success in strengthening in-house talent, as well as bolstering its leadership team with seasoned professionals who have many years of experience growing small businesses across the life sciences spectrum. In recent weeks, the company appointed proven financial leader Nicki Grundy as CFO and raised the highly experienced Caroline O’Connor to CCO.

Alex Garner, COO of Raremark, said: “I’m very pleased to welcome Dale as our new CTO. His exceptional experience and knowledge will play a vital role in developing our platform technology and services, as well as progressing it to the next level. We are continually evolving the way we serve our members and industry clients to help bring new and better rare disease treatments to patients, and Dale will be key to driving them forwards.”

Jeremy Edwards, CEO of Raremark, added: ‘‘2021 is going to be a pivotal year for the business. We’ve seen some extraordinary growth these past 12-plus months and that’s completely down to the incredibly talented team we have been nurturing. We have exciting plans in store for this year and I’m confident in the skills and capabilities of Dale and the rest of our team in taking us there.”